Oculax Acupoint Patch
Natural health product licensed in Canada
- Licence holder
- Oculax Enterprises (Canada) Inc.
- NPN or DIN-HM
- 80042026
- Status
- Active licence
- Licence date
- 30 April 2013
- Revision date
- Not provided
- Form
- Timbre transdermique
- Route of administration
- Transdermique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Ligusticum sinense Source : Plante(s) entière Extraction ratio : 5:1 Dry plant equivalent : 40 mg | 8 mg |
| Angelica sinensis Source : Racine Extraction ratio : 5:1 Dry plant equivalent : 40 mg | 8 mg |
| Chrysanthemum x morifolium Source : Fleur Extraction ratio : 5:1 Dry plant equivalent : 40 mg | 8 mg |
Non-medicinal ingredients
Polyacrylic Acid, Polyethylene terephthalate
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 patch | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps provide relief of symptoms associated with dry eyes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80042026
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.